 we report on our third quarter 2019 financial results and discuss our plans for commercialization of cytisinicline. 
 we also provide an update on our ongoing discussions with potential commercialization partners for commercialization of cytisinicline in the future.    
 # 1_#1 _ # 1_#1 _ =    # 1 1.25 in.125 in.25 in 